buPROpion Hydrochloride
- Product NDC
- 52817-346
- 11-digit product format
- 528170346
- Labeler code
- 52817
- Product ID
- 52817-346_f0d4825a-95dd-48f8-e053-2a95a90aeeb0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- TruPharma LLC
- Application
- ANDA211200
- Marketing category
- ANDA
- Marketing start
- 2022-01-27
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 52817-346-30 | 52817034630 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (52817-346-30) | 2022-01-27 | 0000-00-00 | No | No | Current |
| 52817-346-50 | 52817034650 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (52817-346-50) | 2022-01-27 | 0000-00-00 | No | No | Current |
| 52817-346-90 | 52817034690 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (52817-346-90) | 2022-01-27 | 0000-00-00 | No | No | Current |